Duloxetine Group (n = 30) | Placebo Group (n = 30) | P value | |
---|---|---|---|
Age/years | 45.83 ± 10.4 | 43.83 ± 6.4 | 0.375* |
Sex | |||
Female | 13 (43.3%) | 10 (33.3%) | 0.426** |
Male | 17 (56.7%) | 20 (66.7%) | |
Weight/kg | 84.17 ± 12.5 | 80.67 ± 10.8 | 0.250* |
Height/kg | 163.37 ± 5.9 | 165.43 ± 4.4 | 0.131* |
BMI | 31.23 ± 3.8 | 29.72 ± 3.2 | 0.103* |
ASA | |||
I | 10 (33.3%) | 15 (50%) | 0.250* |
II | 15 (50%) | 9 (30%) | |
III | 5 (16.7%) | 6 (20%) | |
Operative duration (h) | 4.2 ± 0.95 | 4.3 ± 0.95 | 0.847 |
Intravenous fluid (L) | 2.9 ± 0.60 | 2.9 ± 0.56 | 0.834 |